- Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
- Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
- The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube
- AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING
- Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference
- Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results
- AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING
- Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System
- Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Second Quarter Fiscal Year 2023 Financial Results
- Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study
More ▼
Key statistics
On Thursday, Aurora Spine Corp (ASG:CVE) closed at 0.275, 19.57% above the 52 week low of 0.23 set on Aug 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.29 |
---|---|
High | 0.29 |
Low | 0.275 |
Bid | 0.23 |
Offer | 0.300 |
Previous close | 0.300 |
Average volume | 10.65k |
---|---|
Shares outstanding | 70.77m |
Free float | 56.10m |
P/E (TTM) | -- |
Market cap | 21.23m CAD |
EPS (TTM) | -0.0449 CAD |
Data delayed at least 15 minutes, as of Apr 25 2024 17:42 BST.
More ▼